Novel serum lipidomic signature correlates with the grade of steatosis measured biochemically and by magnetic resonance imaging.
Jimenez-Aguero R, Bujanda L, Arretxe E, Balgoma D, Perugorria MJ, Alonso C, Eizaguirre E, Krawczyk M, Lammert F, Castro A, Banales JM.
Journal Of Hepatology. 2016; 64: 484-485. FI: 12,486 (Q1).
Ursodeoxycholic acid in advanced polycystic liver disease: a multicenter randomized controlled phase 2 trial (CURSOR).
D'Agnolo HMA, Kievit W, Takkenberg B, Riano I, Bujanda L, Neijenhuis M, Brunenberg E, Beuers U, Banales, J, Drenth J.
Journal Of Hepatology. 2016; 64: 299-299. FI: 12,486 (Q1).
Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study.
Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Théâtre E, van der Meulen-de Jong AE, Weersma RK, Wilson DC, International Inflammatory Bowel Disease Genetics Consortium, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DP, Barrett JC, Lees CW.
Lancet. 2016; 387: 156-167. FI: 47,831 (Q1).
Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.
Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J.
Endoscopy. 2016; 48: 56-61. FI: 5,444 (Q1).
Functional Analyses of the Crohn’s Disease Risk Gene LACC1.
Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, Mjösberg J, Ruhrmann S, Fabbri A, Vukojevic V, Percipalle P, Salomons FA, Laurencikiene J, Törkvist L, Halfvarson J, D'Amato M.
Plos One. 2016; 11: -. FI: 2,806 (Q1).
Trem-2 protects the liver from immune-mediated hepatocellular damage.
Perugorria MJ, Sharif O, Oakley F, Esparza-Baquer A, Korosec A, Mann J, Labiano I, Tiniakos D, Gawish R, Jimenez-Aguero R, Bujanda L, Banales JM, Knapp S, Mann DA. T
Journal Of Hepatology. 2016; 64: 149-150. FI: 12,486 (Q1).
MIR-873 Promotes liver de-differentiation and fibrosis targeting glycine-n-methyl transferase.
Fernandez-Tussy P, Fernandez-Ramos D, Lopitz-Otsoa F, Barbier-Torres L, Zubiete-Franco I, de Juan VG, Bruix J, Villa E, Fraga M, Fernandez AF, Fabregat I, Perugorria MJ, Banales JM, Delgado, TC, Varela-Rey M, Beraza N, Lu SC, Mato JM, Martinez-Chantar L.
Journal Of Hepatology. 2016; 64: 203-204. FI: 12,486 (Q1).
Endoscopist characteristics that influence the quality of colonoscopy.
Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E, COLONPREV Study Investigators
Endoscopy. 2016; 48: 241-247. FI: 5,444 (Q1).
Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.
Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW, Lynch Syndrome prediction model validation study group.
Jnci-Journal Of The National Cancer Institute. 2016; 108: -. FI: 12,589 (Q1).
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
Marín-Jiménez I, Nos P, Domènech E, Riestra S, Gisbert JP, Calvet X, Cortés X, Iglesias E, Huguet JM, Taxonera C, Fernández R, Carpio D, Gutiérrez A, Guardiola J, Laria LC, Sicilia B, Bujanda L, Cea-Calvo L, Romero C, Rincón Ó, Juliá B, Panés J. INFLAMMATORY BOWEL DISEASE.
American Journal Of Gastroenterology. 2016; 111: 261-268. FI: 9,566 (Q1).
Effect of pravastatin on the survival of patients with advanced gastric cancer.
Bujanda L, Rodríguez-González A, Sarasqueta C, Eizaguirre E, Hijona E, Marín JJ, Perugorria MJ, Banales JM, Cosme A.
Oncotarget. 2016; 7: 4379-4384. FI: 5,168 (Q1).
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Banales JM, Hogan MC, Tasic V, Watnick TJ, Chapman AB, Vigneau C, Lavainne F, Audrézet MP, Ferec C, Le Meur Y, Torres VE, Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease, Harris PC.
American Journal Of Human Genetics. 2016; 98: 1193-1207. FI: 9,025 (Q1).
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A, Oncology Group of the Asociación Española de Gastroenterología (AEG).
Plos Medicine. 2016; 13: -. FI: 11,862 (Q1).
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, Geier A, Calvisi DF, Mertens JC, Trauner M, Benedetti A, Maroni L, Vaquero J, Macias RI, Raggi C, Perugorria MJ, Gaudio E, Boberg KM, Marin JJ, Alvaro D. E
Nature Reviews Gastroenterology & Hepatology. 2016; 13: 261-280. FI: 13,678 (Q1).
